UNSPSC 51101639: Clamoxyquin

This classification denotes an antiprotozoal agent with the molecular formula C17H24ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JUN13FZ6RF, chemically known as cn-17,900-2b but generally known as clamoxyquin, which bears US NIH Compound Identifier 18029. European Medicines Agency schedules Clamoxyquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06637MIG.

The term CLAMOXYQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). As of Q4 2014, CLAMOXYQUIN remains the US FDA Preferred Term for this commodity. Clamoxyquin bears US NLM identifiers UMLS ID C2699337 and NCI Concept Code C78097. SMILES: CCN(CC)CCCNCC1=CC(=C2C=CC=NC2=C1O)CL.

UNSPSC 51101639 Clamoxyquin is a Commodity code that state and local governments use to classify pharmaceutical products, though the recent activity under this code shows little direct purchasing of clamoxyquin itself. Instead, the opportunities posted under this code reflect broader pharmaceutical procurement by public health agencies and counties — including antibiotics, naloxone, and drug deactivation systems acquired through both direct purchase and cooperative purchasing vehicles. The issuing bodies soliciting under this code are state health departments and county health systems, which use it to classify emergency medical supplies and preventive-care pharmaceuticals alongside their broader inventory management.

Recent opportunities show activity in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — a $2,999,999.11 contract over 12 months with two optional renewal years, using an Invitation for Bid process. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, for procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford; the response deadline was July 26, 2023. The code shows limited recent activity and the opportunities posted do not consistently align with clamoxyquin procurement specifically, suggesting this code may be underutilized or misapplied for the pharmaceutical categories state and local buyers actually pursue.